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ABSTRACT
Objective: To examine patients’ understanding of
hospital-associated thrombosis, and their experiences
of thromboprophylaxis.
Design: Qualitative study using semi-structured
interviews with 31 patients requiring venous
thromboembolism (VTE) prophylaxis following a recent
hospital admission. Interviews were audio-recorded,
transcribed verbatim and analysed thematically using
framework analysis.
Setting: 4 hospitals in Birmingham and Oxford.
Results: All the participants received
thromboprophylaxis following surgical procedures.
Participants were aware of a risk of blood clots;
however, they lacked a good understanding of VTE
and its components. Experiences of VTE prophylaxis
were characterised with good adherence to heparin
injections and poor adherence to elastic
compression stockings, largely due to perceived lack
of clarity in guidance from health professionals.
Participants had limited knowledge of the signs and
symptoms of VTE and would value improved
education on VTE.
Conclusions: Findings suggest that patient
education is often inadequate and impacts negatively
on patients’ involvement in VTE prevention. An
enhanced patient education programme
incorporating a consistent message on the
appropriate use of elastic compression stockings and
description of VTE symptoms is likely to optimise
the effectiveness of the prevention of hospital-
associated thrombosis. Physicians may use the
results of this study to improve individual patient
education.
INTRODUCTION
Patient involvement is an important aspect of
the prevention of hospital-associated throm-
bosis (HAT) yet, to date, much of the focus
on preventing HAT has been on health pro-
fessionals’ implementation of the venous
thromboembolism (VTE) prevention strategy
and associated outcomes, and there is little
understanding of patients’ perceptions and
experiences of HAT prevention. HAT can
occur up to 90 days postdischarge from hos-
pital, and it is recognised that patients are at
increased risk during this time with most
cases of HAT occurring following discharge.1
With current trends towards enhanced recov-
ery and early postsurgery hospital discharge,
a signiﬁcant proportion of hospitalised
patients at risk of VTE are discharged with
mechanical prophylaxis (usually antiembo-
lism stockings) and/or pharmacological
prophylaxis (usually self-administered injec-
tions of low molecular weight heparin).2–5
Therefore, a lot of responsibility falls on the
patient with regard to appropriate use and
adherence to VTE prophylaxis and recogni-
tion of possible VTE episodes for timely
medical intervention.
VTE comprises the acute conditions deep
vein thrombosis (DVT) and pulmonary
embolism (PE); DVT occurs when a blood
clot forms in the deep veins (usually lower
legs) and PE is a potentially fatal complica-
tion which occurs when some or the entire
clot detaches and travels to the lungs. A
recent US study found that while patients
were generally aware of the beneﬁts of antith-
rombotic therapy, only 6 out of 12 interviewed
patients had a clear understanding of DVT
and PE.6 Also adherence has been identiﬁed
as a problem with patients prescribed throm-
boprophylaxis both internationally and in the
UK.7–10 It has been hypothesised that patients
Strengths and limitations of this study
▪ Mixed variety sample of patients requiring
venous thromboembolism prophylaxis following
a recent hospital admission.
▪ Interviews were audio recorded, transcribed ver-
batim and independently checked for accuracy.
▪ Data analysis was iterative and independent of
the interviewing researcher.
▪ Over-representation of surgical patients.
▪ Participants were predominantly of white British
ethnicity.
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are not adequately educated about the rationale for
thromboprophylaxis; however, this has not been fully elu-
cidated and no qualitative research has explored HAT
prevention from the patients’ perspective. This qualitative
study, embedded within a larger study exploring the pre-
vention and knowledge of VTE (ExPeKT) aimed to
explore patients’ awareness of VTE and their experiences
VTE prophylaxis.11
METHODS
Face-to-face interviews were carried out with patients
classed by hospital staff as being at high risk of develop-
ing VTE during a recent hospital admission. The ration-
ale of using interviews was to allow detailed exploration
of personal perceptions and individual experiences
without the contamination of other participants’ views.
Participants were drawn from respondents to a survey
conducted as part of the broader ExPeKT study.11 The
survey was distributed to 868 inpatients assessed to be at
high risk of VTE, recruited from medical, surgical and
orthopaedic wards in two acute trusts in Oxford and
Birmingham. Of these, 564 patients returned completed
questionnaires and 238 conﬁrmed they would be pre-
pared to be interviewed.
Purposeful sampling12 was employed to select inter-
view participants of maximum variety of age, gender,
condition requiring hospital stay and site. This was to
ensure that the sample reﬂected a varied range of
patients to minimise the risk of the study being distorted
to one perspective. A topic guide was developed through
discussion with the research team, and comprised open-
ended questions that drew reﬂections on patients’
recent hospital admissions with particular reference to
their understanding of VTE risk and their experiences
of how this risk was assessed and managed (see online
supplementary appendix 1).
Data collection continued until theoretical saturation
was attained.13 Semistructured interviews were con-
ducted with a total of 31 patients and they all took place
in the patients’ homes. All participants provided
informed consent prior to the interviews. The inter-
viewer was a woman, a non-clinical researcher (PhD)
trained in qualitative research; she was not known to par-
ticipants prior to the study, and participants were made
aware that she was conducting the interviews as part of
her job. The interviews lasted between 10 and 45 min;
all were audio recorded and transcribed verbatim.
Veriﬁcation of interview data was completed through tri-
angulation with the corresponding survey responses to
establish credibility and dependablity.14
Analysis
PNA, IL and SG independently read through the same
three interview transcripts to familiarise themselves with
the interviews and identify emerging themes. They then
met to compare, discuss and ﬁnalise themes for the
coding frame.15 Based on this PNA subsequently coded
the remaining interviews using NVivo software to
manage the data which was analysed using framework
analysis16 (see online supplementary appendix 2).
RESULTS
Participant characteristics
Participants’ characteristics were extracted from pat-
ient questionnaires administered as part of the wider
ExPeKT study11 (table 1). Of the 31 participants, 55%
were men and ages ranged from 38 to 81 years with
a mean age of 63. The majority (94%) were of white
British ethnicity and 87% had received at minimum an
‘O level’ education or earned a professional
qualiﬁcation.
All the participants were surgical patients, 87% were
planned admissions and the remainder were emergency
admissions. In total, 58% underwent orthopaedic
surgery (hip or knee replacement). All the participants
received VTE prophylaxis, with 77% receiving both com-
pression stockings and heparin injections.
Findings are presented in ﬁve main themes: awareness
of VTE risk, experience of VTE prophylaxis, knowledge
Table 1 Participants’ characteristics
Variable N=31 Per cent
Male, n (%) 17 54.8
Age groups (years)
≤40 3 9.7
41–64 11 35.5
65–74 12 38.7
≥75 4 12.9
Not known 1 3.2
White British ethnicity 29 93.5
Highest level of education received
O or A level 6 19.4
Degree 9 29.1
Professional/commercial 12 38.7
Not known/none 4 12.9
Admission
Planned admission 27 87.1
Emergency admission 4 12.9
Length of hospital stay, number of days
≤3 7 22.6
1–6 17 54.8
≥7 7 22.6
Condition requiring hospital admission
Orthopaedic surgery 18 58.1
Gastrointestinal surgery 7* 22.6
Other surgery 6† 19.3
VTE prophylaxis
Stockings only 5 16.1
Injectable prophylaxis only 2 6.5
Both stockings and injectable
prophylaxis
24 77.4
*One was oncology related.
†Three were oncology related.
VTE, venous thromboembolism.
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of VTE symptoms, postdischarge support and perceived
gaps in patient education (ﬁgure 1).
Awareness of VTE risk
Patients reported being aware of risk of blood clots asso-
ciated with their recent hospital admission; though they
did not refer speciﬁcally to the terms DVT or PE. In par-
ticular, patients booked for planned orthopaedic surgery
described a presurgical assessment which entailed a dis-
cussion on all the risks relating to their surgery includ-
ing risk of blood clots.
I just remember the general things that there is obviously
a substantial risk of clotting and that they take certain
precautions to ensure that they manage that sort of
during and after the process. Female aged 69, total hip
replacement
Yes they were very good. They covered all those points
honestly, they did point out lower limb surgery, increased
risk etc. Best thing to do, and that’s come through repeat-
edly, is keep moving.Male aged 56, total hip replacement
However, information given to a patient in the preas-
sessment for non-orthopaedic surgery seemed to miss
out the emphasis on blood clots:
I mean I know when you have your pre-op they do your
blood pressure and everything, yes. But at no time, in
fact, were blood clots actually mentioned. Female aged 68,
stoma reversal
Patients’ source of awareness of VTE appeared to be
mainly from information given in work up to the recent
surgical admission or a previous surgery of themselves or
a family member.
Q: Before you went into hospital were you aware of the
risks of blood clots associated with being in hospital?
A: Yes, I think so, largely because, I’m having been in
previously for various bits and pieces over my life, y’know,
I was aware that they can happen but fortunately there’s
no family history so, not too concerned. And also every-
one explains these things at each time, all the various
risks that are associated. Female aged 62, knee replacement
VTE risk assessment: Patients appeared not to be aware
of undergoing a VTE risk assessment and many pre-
sumed that the VTE prophylaxis was part of a general
approach rather than a tailored treatment due to their
being at high risk.
I had a pre-med, they checked my blood pressure and
everything, but no I wasn’t aware of being risk assessed
for that particular condition (blood clots). Female aged 63,
ovarian cysts
Experience of VTE prophylaxis
Patients described their perceptions and experiences of
heparin injections and compression stockings.
Injections: perceptions and adherence: Twenty-four out of
26 patients given heparin injections as part of their
Figure 1 Themes and
subthemes. HAT,
hospital-associated thrombosis;
VTE, venous thromboembolism.
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hospital admission had to self-administer the heparin
injections at home postdischarge. Patients’ narratives
portrayed mixed views of having to self-inject; some
reported they were not keen on self-administering the
injections while others had no problem with it and did
it routinely. Patients described the differing levels of
guidance provided on injecting the chemoprophylaxis.
Some received training by a nurse that included a dem-
onstration and observation while others recalled being
handed the injection set on discharge and instructed to
maintain the course of injections. Despite these discrep-
ancies all participants discharged with heparin injections
reported completing the course of injections though
some had help from an adult child or partner.
I mean I’m not particularly a squeamish kind of person,
so I wasn’t particularly nervous about it. I didn’t like the
idea when I ﬁrst had to do them the ﬁrst time, but, realis-
ing effectively that there isn’t a choice, just get on and do
it. So…y’know 6 o’clock every night the ol’ thing came
out…I had quite a few bruises on my tummy…as time
went on I suppose y’know, it did become more painful.
But y’know, needs must, if that’s what you’ve got to do,
that’s what you’ve got to do. Female aged 62, knee replacement
Generally patients understood that the injections were
to prevent blood clots; however, two patients had limited
understanding of the rationale for the injections and
viewed them as part of the treatment of their condition,
and did not necessarily associate them with VTE
prevention.
Q: So what treatment did you receive, to prevent blood
clots?
A: Now, was I given any pills, the week before. On that
visit, we were given some pills…no I don’t think before
the operation I had anything speciﬁc for blood clots.
Q: Did you have anything whilst you were in hospital do
you know?
A: I’m sure they were giving me something, they were
giving me various pills, but again, they didn’t necessarily
tell me, as I recall, what it was for.
Q: What about when you left the hospital. Did they give
you anything to bring home?
A: I don’t think so; I mean I had the support stockings…
Q: Did you have any injections? Injections in the
stomach?
A: Yes, ah, is that, was that, I’d forgotten that now. I was
given these—I had to inject myself for, a month?
Q: Yes, now that is an anticoagulant
A: Right, perhaps I had forgotten that. Male aged 63, total
hip replacement
Elastic compression stockings: perceptions and adherence: A
total of 29 patients reported receiving elastic compres-
sion stockings during their hospital admission and
described their experiences. Overall, there was inconsist-
ency in the administration of the stockings and some
participants described coming round from surgery to
ﬁnd the stockings on, with no explanations. Patients’
narratives pointed to a lack of clarity on the use of stock-
ings and few patients (7/29) wore them for prescribed
length of time. Patients described multifaceted reasons
for non-adherence; guidance on stockings use seemed
to be rather potluck—very few were clear that they were
to continue to wear them postdischarge and/or how
long they were to wear them for.
Q: Did you wear the stockings all of time?
A: For the full length I was in there, yeah.
Q: And when you came out?
A: Didn’t wear them when I came out.
Q: Were you supposed to?
A: Well no I don’t think so…I didn’t wear them when I
came out no, no. Although they did give me four or ﬁve
pairs. Male aged 38, lump removed from right leg
Some patients discontinued wearing stockings after a
while due to discomfort, choosing to exercise and/or
stay mobile in place of the stockings or a perception that
their personal risk of VTE was low.
I carried on for a little while, but they made my legs
worse. I felt they were too tight…My daughter in law is a
physiotherapist- because I was so active, she thought I
would be alright without sort of thing…so uncomfortable
they bit into you around the top here leg and all that
y’know. Male aged 73, knee replacement
Patients also reported contradictions in information
received regarding stockings, with conﬂicting informa-
tion from nurses, doctors and information leaﬂets. This
made it difﬁcult for patients to know the correct course
of action, and one patient was told he no longer
needed to wear the stockings once the injections were
started.
The nurse said wear them for a fortnight which is what I
did and then reading the leaﬂet afterwards it said keep
wearing the stockings for after six weeks but I only wore
them for a fortnight. Male aged 69, hip replacement
I suppose that’s probably the most unclear part of the
whole procedure. The injections were ﬁne, I was quite
happy with y’know, doing and administering it and that
whole process. Obviously the stockings were worn in the
hospital sort of continuously and then I think the infor-
mation you get, the information sheets is wear of up to
four weeks post op, but there was deﬁnitely conﬂicting
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advice from the nursing staff. Some of the nurses were,
‘well it’s not that serious if you don’t wear them’ others
were ‘absolutely must wear them.’ So, y’know there was
deﬁnitely conﬂicting advice. Female aged 40, hip replacement
revision
Some of the patients who wore elastic compression
stockings for the prescribed period (often 6 weeks) also
reported of discomfort in terms of tightness and chal-
lenges of getting them on and off, and many required
help from a spouse or partner.
Interestingly many patients reported saving their stock-
ings for ﬂying.
Knowledge of VTE symptoms
Inadequate knowledge of symptoms: One-third of the inter-
viewed patients were of the opinion that they would
not recognise symptoms of a blood clot. The other
two-thirds described vague symptoms relating to DVT
with ‘pain in lower leg’ being the most cited symptom,
with a few mentioning tenderness, soreness, redness and
swelling. Patients’ responses demonstrated a lack of
awareness of potentially fatal PE and only two patients
described symptoms of PE, describing it as ‘when the
clot travels to the lungs’ and cited symptoms such as
shortness of breath, and tachycardia.
I mean, I know there is a risk but I wouldn’t know how to
assess whether or not I was having a blood clot. Female
aged 63, ovarian cysts
Well if you’re gonna ask me now what are the symptoms
I’m gonna say I can’t remember. I think discolouration,
and probably pain in your leg. I don’t know if you get to
the stage of passing out do you? Male aged 63, hip
replacement
Reaction in the event of symptoms: All participants said
they would seek medical attention if they thought they
were having a blood clot, some opting to go to the gen-
eral practitioner (GP) and others recognising it as a
medical emergency.
I would, I don’t know, it depends how bad it was I
suppose. I might go straight to A and E or, go to the
doctor. But I would know that it’s urgent. Male aged 79,
knee replacement
Postdischarge support
Perceived role of primary care: The interviews explored the
need for postdischarge support from GP/district nurse.
Generally patients were of the opinion that it was not
necessary to routinely activate GP involvement post-
discharge, and many could not see the point and found
it difﬁcult to envision a role for primary care in this
area. Patients reported that they had all coped ﬁne with
the current system and were empowered to contact their
GP if they had any concerns. A few said they would ﬁnd
it reassuring just to know they were doing the right
thing due to the long time period between discharge
from surgery and follow-up consultations.
That’s quite interesting actually, I think I never thought
about in terms of the GP but the one thing I did sort of
think about during the whole recovery process is you
kind of sort of leave hospital and that’s it until you have
your check-up so, you do hit moments where I think you
do wonder is everything going ok even if you’ve got no
reason to be, to question it. Am I doing the right thing?
Should I be doing this? Shouldn’t I be doing that? And
there isn’t really anyone to call. So whether it’s a visit
from the GP that would be, a good idea or whether it’s a
district nurse or whether even it’s a physio, I think in that
period between sort of discharge and you follow up con-
sultation I think, it’s too long a gap without some, just
reassurance really, nothing more than that. Female aged
40, hip replacement revision
Perceived gaps in patient education
Patient education and public awareness: Patients would
however value more education on VTE, in terms of how
the VTE prophylaxis works, clarity on stockings use and
some information on symptoms in order to recognise if
they were having a blood clot. One patient who had
experienced a minor bleeding episode said it would
have been useful to have been warned about possible
side effects of pharmacological prophylaxis. Patients also
touched on lack of public awareness of VTE and sugges-
tions to deal with this included public campaign.
Y’know there’s the sort of checklist that they have to ﬁll
before you’re discharged. Y’know have you got your
meds? Have you got this have you got that? Maybe that’s
the point at which they just need to sit with patients
again and say, ‘right, let’s just remember some key things
y’know, do you know how to identify infection or blood
clot?’…Y’know take an extra ten minutes per patient on
discharge to go through a number of key risk areas is
probably the one thing that could be, looked at. Female
aged 40, hip replacement revision
DISCUSSION
The ﬁndings of this qualitative study give insights into
patients’ experiences of VTE prevention. Despite an
awareness of VTE risk, patients did not appear to have a
good understanding of the components of VTE and its
potentially fatal complications. Patients were aware it was
important to seek medical advice if they thought they
had a VTE but appeared to lack the knowledge to assess
its onset and important knowledge on signs and symp-
toms of VTE was limited.
Though our study found good adherence to injectable
prophylaxis, there was poor adherence to antiembolism
stockings due perhaps to a lack of clarity in patient
education.
The National Institute for Health and Care Excellence
(NICE) guidelines for VTE prevention recommend that
patients discharged with VTE prophylaxis are offered
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verbal and written information on the signs and symp-
toms of DVT and PE, and the correct and recom-
mended duration of use of VTE prophylaxis at home. It
also recommends patients are educated about the
importance of using VTE prophylaxis correctly, adher-
ence and the importance of seeking help if they have
any problems using the prophylaxis or DVT, PE or other
adverse events are suspected.2 Our ﬁndings are incon-
sistent with these recommendations with patients having
huge gaps in knowledge of symptoms and requirements
relating to stockings use.
The ﬁnding relating to high adherence to injectable
prophylaxis must be interpreted within the context of
the study sample which was predominantly orthopaedic
patients who had presurgical a session involving educa-
tion on VTE prevention. Similarly this accentuates the
signiﬁcance of the ﬁnding relating to limited knowledge
on signs and symptoms of VTE.
The literature supports the premise that improving a
patient’s understanding of the rationale for a medication
increases adherence,17 and this has been proven to
apply to VTE prevention—a US study found individua-
lised patient education sessions on thromboprophylaxis
was associated with higher adherence to injectable
prophylaxis.18 Another study found that discharge coun-
selling was associated with improved adherence after
hospital discharge for myocardial infarction.19
Strengths and limitations
To the best of our knowledge, this is the ﬁrst qualitative
study to explore hospitalised UK patients’ perceptions
and experiences of VTE prevention, incorporating
awareness of VTE risk and VTE prophylaxis. Face-to-face
interviews provided in-depth exploration of the issues,
and analysis was iterative and independent of the inter-
viewing researcher. The research team was multidis-
ciplinary and offered different perspectives which
enhanced interpretation of the data.
Surgical patients were over-represented, and inclusion
of medical patients would have provided a broader repre-
sentation of hospitalised patients; however, this was a
feature of the composition of the survey respondents and
ﬁndings have been interpreted in the context of this. The
sample was also predominantly of white British ethnicity.
Nevertheless, a maximum variety sample20 allowed a mix
of participants from the sampling frame, and interviews
were conducted to the point of theoretical saturation.
Given the high proportion of orthopaedic surgical
patients who often have VTE education embedded into
the presurgical assessments, ﬁndings may overestimate
the VTE awareness and adherence to VTE prophylaxis.
Comparison with existing literature
Patients in our study had inadequate knowledge of symp-
toms of DVT and PE to enable appropriate self-
assessment and self-reporting of possible VTE episodes.
In addition, they did not appear to recognise the real
personal risk of VTE.
Our ﬁnding that patients lack a clear understanding
of VTE is consistent with previous research; a recent US
study found that while hospitalised patients were aware
of risk of VTE following orthopaedic surgery and the
beneﬁts of VTE prophylaxis many did not have a clear
understanding of VTE.6 A survey in Canada found that
only 6% patients who had received thromboprophylaxis
as part of a hospital stay were aware of the complication
of a blood clot travelling to the lungs, and 20% were not
able to correctly identify a single symptom of DVT.21
The communication of risk is a difﬁcult part of clinical
practice22 and evidence suggests that the format in
which risk information is presented affects patients’
understanding and perception of risk.23 Some areas of
risk communication still lack strong evidence,23 never-
theless the communication of VTE risk should aim to
inﬂuence patient awareness of VTE and correct inappro-
priate risk perception to facilitate patients to reduce
their risk. It is therefore important for patients to be
aware that they have been assessed as high risk of VTE.
The literature also suggests inadequate public knowl-
edge of VTE and a recent UK street survey reported
limited public knowledge of DVT and highlighted the
need for raising general awareness of DVT with particu-
lar focus on its complications.24
Our ﬁnding relating to injectable prophylaxis is con-
trary to the literature which indicates suboptimal ad-
herence to heparin injections7 8 with non-adherence
ranging from 21% to 37%.7 Our study also found that
patients often did not receive enough information to
support proper use of elastic compression stockings
resulting in poor adherence. This is consistent with the
literature and other researchers have observed that some
inpatients are offered stockings in a perfunctory manner
with poor or limited patient education on VTE.25 26
Provider–patient communication in hospitals is fre-
quently problematic and often further complicated
during hospital discharge.27 28 Incorporating the pat-
ient’s perspective enriches and improves communication
between providers and patients, and integrating collab-
oration and patient empowerment has positive outcomes
in relation to patient satisfaction and healthcare
outcomes.29
CONCLUSION
This study addresses an important aspect of VTE preven-
tion and identiﬁes gaps in patient education that hinder
patients’ role in VTE prevention. While some patients
are aware of the appropriate use of pharmacological and
mechanical prophylaxis postdischarge, many lacked
important knowledge on the use of antiembolism stock-
ings and symptom recognition of DVT and PE. Patients
need a basic but comprehensive understanding of VTE
and appropriate use of VTE prophylaxis to complete
their participation in VTE prevention.
Suboptimal adherence to VTE prophylaxis and the
lack of awareness of VTE symptoms compromise VTE
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prevention and puts patients at risk of adverse events;
therefore, more attention must be paid to patient
involvement in VTE prevention. Improved patient edu-
cation incorporating VTE risk will motivate adherence
to VTE prophylaxis, and education on recognition of
symptoms will equip patients to self-assess and self-report
possible VTE events. Ongoing initiatives such as
Thrombosis UK and World Thrombosis Day may help to
increase awareness and improve the understanding of
venous thrombosis. Nevertheless, patient education must
be systematic and standardised across the National
Health Service (NHS) to optimise the effectiveness of
the national VTE prevention strategy.
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